| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |